Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

6000b840-3737-4612-912f-c959b8c03437 - samples

ABSTRACT: RNA-seq data for melanoma biopsies at baseline and after treatment

PROVIDER: EGAD00001009059 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

ed2bceaf-a78f-4d77-a8f5-e2f349d9aa99 - samples

Project description:RRBS data for melanoma biopsies at baseline and after treatment

| EGAD00001009060 | EGA

Developing biomarkers incorporating high throughput RNA, DNA, small RNA sequencing and protein expression in Inflammatory Bowel Disease using formalin-fixed, paraffin-embedded (FFPE) tissue samples.

Project description:This dataset includes RNA-seq data from ileal and colonic biopsies at time of diagnosis for treatment-naive, uncomplicated Crohn's disease (CD) patients and matched controls. This is includes 56 CD patients each for ileal and colonic tissue and for controls, 46 colonic samples and 45 ileal samples. Clinical characteristics such as development of complications, disease remission, or progression to surgery were recorded with a mean follow-up of 6 years.

2024-02-07 | GSE221161 | GEO

Exploration of tumor associated macrophages in patients with metastatic uveal melanoma by single cell RNAseq

Project description:Pre- and post-treatment tumor biopsies from 8 patient with metastatic uveal melanoma patients were analysed by single cell RNAseq. Transcriptomic profiling of myeloid populations including macrophages, monocytes, and dendritic cells was carried out. M2 macrophage subsets were identified at baseline and treatment-induced M2 to M1 macrophage reprogramming was characterised.

2025-02-05 | GSE287090 | GEO

Single-cell RNA-seq profiling of treatment-naïve chemo-refractory and chemo-sensitive ovarian cancer

Project description:This dataset contains single-cell RNA-seq data from treatment-naïve biopsies of nine patients diagnosed with ovarian high-grade serous carcinoma (HGSC), including four chemo-refractory and five chemo-sensitive cancers. Four of the samples (EOC204, EOC115, EOC649, EOC1127) are newly generated, while five samples have been previously published (GSE165897). The data was generated as part of the DECIDER observational trial (NCT04846933) to investigate the molecular drivers of chemo-refractory HGSC. Key findings from the study indicate that chemo-refractory HGSC is associated with reduced interferon type I (IFN-I) activity and enhanced hypoxia pathway activity, while baseline IFN-I pathway activity in chemo-naïve cancer serves as an independent prognostic factor for chemotherapy response.

2025-07-03 | GSE300897 | GEO

Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small-cell lung cancer

Project description:We report RNA-sequencing data of 286 platelet RNA samples isolated from non-small cell lung cancer patients (NSCLC) that were at baseline for nivolumab immunotherapy. This dataset was employed to test the hypothesis that platelet RNA at baseline of nivolumab treatment predicts immune responses.

2023-07-10 | GSE216297 | GEO

RNA-seq of pre-treatment and post-relapse matched samples from melanoma patients

Project description:RNA-seq of pre-treatment and post-relapse matched samples from melanoma patients RNA-seq was performed for matched samples before treatment and after relapse from six patients that have been treated with RAF or RAF+MEK inhibitors. Submitter declares that raw sequence data will be submitted to dbGaP due to patient privacy concerns.

2016-02-25 | E-GEOD-77940 | biostudies-arrayexpress

Sammut2022 - Multi-omic machine learning model to predict pathological complete response for breast cancer neoadjuvant therapy

Project description:In this publication, researchers investigated the intricate relationship between breast cancers and their microenvironment, specifically focusing on predicting treatment responses using multi-omic machine learning model. They collected diverse data types including clinical, genomic, transcriptomic, and digital pathology profiles from pre-treatment biopsies of breast tumors. Leveraging this comprehensive multi-omic dataset, the team developed ensemble machine learning models using different algorithms (Logistic Regression, SVM and Random Forest). These predictive models identifies patients likely to achieve a pathological complete response (pCR) to therapy, showcasing their potential to enhance treatment selection. Please note that the authors also have an interactive dashboard to apply the fully-integrated NAT response model on new (or any desired) data. The user can find its link in their GitHub repository: https://github.com/micrisor/NAT-ML For more information and clarification, please refer to the ReadMe_NAT-ML document in the files section.

2023-08-28 | BIOMD0000001075 | BioModels

Coffee remodels the histone acetylation landscape in association with suppression of the MYC transcriptional program

Project description:This dataset contains data-independent acquisition (DIA) proteomics data generated from K562 human leukemia cells treated with coffee extract or vehicle control. Quantitative proteomic analysis was performed to investigate molecular mechanisms underlying coffee-induced epigenetic remodeling. The proteomics dataset was integrated with histone modification profiling, ChIP-seq and RNA-seq analyses to characterize pathways associated with histone acetylation and MYC transcriptional regulation.

2026-07-08 | PXD080702 | JPOST Repository

RNA-seq of pre-treatment and post-relapse matched samples from melanoma patients

Project description:RNA-seq of pre-treatment and post-relapse matched samples from melanoma patients

2016-02-25 | GSE77940 | GEO

Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial

Project description:Thirty patients with advanced melanoma were recruited to a clinical trial investigating the therapeutic cancer vaccine, UV1, in combination with pembrolizumab. Whole exome sequencing was performed on melanoma biopsies to determine tumor mutational burden and association with response to therapy. RNA sequencing of matched tumor biopsies to evaluate gene expression profiles at baseline and post-treatment.

| EGAS00001007210 | EGA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data